2. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin 1999; 49: 33–64, 1.
3. Peeters M, Haller DG. Therapy for early-stage colorectal cancer. Oncology (Huntingt) 1999; 13: 307–321.
4. Winawer SJ, Zauber AG. The advanced adenoma as the primary target of screening. Gastrointest Endosc Clin N Am 2002; 12: 1–9, v.
5. Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: Clinical guidelines and rationale. Gastroenterology 1997; 112: 594–642.
6. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy: The National Polyp Study Workgroup. N Engl J Med 1993; 329: 1977–1981.
7. Winawer SJ, Zauber AG, O’Brien MJ, et al. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps: The National Polyp Study Workgroup. N Engl J Med 1993; 328: 901–906.
8. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759–767.
9. Lieberman DA. Cost-effectiveness model for colon cancer screening. Gastroenterology 1995; 109: 1781–1790.
10. American Cancer Society. ACS cancer facts and figures. Cancer Pract 2000; 8: 105–108.
11. Lieberman DA, Weiss DG, Bond JH, et al. Use of colonoscopy to screen asymptomatic adults for colorectal cancer: Veterans Affairs Cooperative Study Group 380. N Engl J Med 2000; 343: 162–168.
12. Lieberman DA, Weiss DG. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med 2001; 345: 555–560.
13. Imperiale TF, Wagner DR, Lin CY, et al. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med 2000; 343: 169–174.
14. Scala M. Medicare preventive services. Issue Brief Cent Medicare Educ 2001; 2: 1–8.
15. Anderson LM, May DS. Has the use of cervical, breast, and colorectal cancer screening increased in the United States? Am J Public Health 1995; 85: 840–842.
16. Bloom Y, Figgs LW, Baker EA, et al. Data uses, benefits, and barriers for the behavioral risk factor surveillance system: A qualitative study of users. J Public Health Manag Pract 2000; 6: 78–86.
17. Ounpuu S, Krueger P, Vermeulen M, et al. Using the U.S. Behavior Risk Factor Surveillance System’s health related quality of life survey tool in a Canadian city. Can J Public Health 2000; 91: 67–72.
18. Burt RW. Colon cancer screening. Gastroenterology 2000; 119: 837–853.
19. Costanza ME, Hoople NE, Gaw VP, et al. Cancer prevention practices and continuing education needs of primary care physicians. Am J Prev Med 1993; 9: 107–112.
20. Pommerenke FA, Dietrich A. Improving and maintaining preventive services: Part 2—Practical principles for primary care. J Fam Pract 1992; 34: 92–97.
21. Wender RC. Cancer screening and prevention in primary care: Obstacles for physicians. Cancer 1993; 72 (3 Suppl): 1093–1099.
22. Ling BS, Moskowitz MA, Wachs D, et al. Attitudes toward colorectal cancer screening tests. J Gen Intern Med 2001; 16: 822–830.
23. Pignone M, Bucholtz D, Harris R. Patient preferences for colon cancer screening. J Gen Intern Med 1999; 14: 432–437.
24. Dominitz JA, Provenzale D. Patient preferences and quality of life associated with colorectal cancer screening. Am J Gastroenterol 1997; 92: 2171–2178.
25. Hegarty V, Burchett BM, Gold DT, et al. Racial differences in use of cancer prevention services among older Americans. J Am Geriatr Soc 2000; 48: 735–740.
26. Chao A, Gilliland FD, Hunt WC, et al. Increasing incidence of colon and rectal cancer among Hispanics and American Indians in New Mexico (United States), 1969–1994. Cancer Causes Control 1998; 9: 137–144.
27. Brown MO, Lanier AP, Becker TM. Colorectal cancer incidence and survival among Alaska Natives, 1969–1993. Int J Epidemiol 1998; 27: 388–396.
28. Mayberry RM, Coates RJ, Hill HA, et al. Determinants of black/white differences in colon cancer survival. J Natl Cancer Inst 1995; 87: 1686–1693.
29. Baquet CR, Commiskey P. Colorectal cancer epidemiology in minorities: A review. J Assoc Acad Minor Phys 1999; 10: 51–58.
30. Hoffman-Goetz L, Breen NL, Meissner H. The impact of social class on the use of cancer screening within three racial/ethnic groups in the United States. Ethn Dis 1998; 8: 43–51.
31. Roetzheim RG, Pal N, Tennant C, et al. Effects of health insurance and race on early detection of cancer. J Natl Cancer Inst 1999; 91: 1409–1415.
32. Weller DP, Owen N, Hiller JE, et al. Colorectal cancer and its prevention: Prevalence of beliefs, attitudes, intentions and behaviour. Aust J Public Health 1995; 19: 19–23.
33. Lacey L. Cancer prevention and early detection strategies for reaching underserved urban, low-income black women: Barriers and objectives. Cancer 1993; 72 (3 Suppl): 1078–1083.
34. Gregg J, Curry RH. Explanatory models for cancer among African-American women at two Atlanta neighborhood health centers: The implications for a cancer screening program. Soc Sci Med 1994; 39: 519–526.
35. Lantz PM, Reding D. Cancer: Beliefs and attitudes of migrant Latinos. JAMA 1994; 272: 31–32(letter).
36. Lantz PM, Dupuis L, Reding D, et al. Peer discussions of cancer among Hispanic migrant farm workers. Public Health Rep 1994; 109: 512–520.
37. Solis JM, Marks G, Garcia M, et al. Acculturation, access to care, and use of preventive services by Hispanics: Findings from HHANES 1982–1984. Am J Public Health 1990; 80 (Suppl): 11–19.
38. Trevino FM, Moyer ME, Valdez RB, et al. Health insurance coverage and utilization of health services by Mexican Americans, mainland Puerto Ricans, and Cuban Americans. JAMA 1991; 265: 233–237.
39. Leard LE, Savides TJ, Ganiats TG. Patient preferences for colorectal cancer screening. J Fam Pract 1997; 45: 211–218.
40. Elwood JM, Ali G, Schlup MM, et al. Flexible sigmoidoscopy or colonoscopy for colorectal screening: A randomized trial of performance and acceptability. Cancer Detect Prev 1995; 19: 337–347.